Anti-Spike protein [Sb23]
AB02062-23.159-BT
ApplicationsELISA, Neutralisation/Blocking, Other Application
Product group Antibodies
ReactivityVirus
TargetS
Overview
- SupplierAbsolute Antibody
- Product NameAnti-Spike protein [Sb23]
- Delivery Days Customer9
- Antibody SpecificityThis antibody is capable of binding both recombinant RBD as well as to the pre-fusion spike glycoprotein with high affinity. Sb23 binds an epitope in the ACE2 binding site on the RBD in both its up and down conformation and thereby effectively blocks ACE2
- Application Supplier NoteSb23 binds RBD with a very high affinity and neutralizes pseudovirus with an IC50 of 0.6 microg/ml. Sb23 and ACE2 compete for the same or overlapping binding sites on SARS-CoV-2-RBD. ELISA was used to screen the libraries to identify specific RBD binders. It is also reported that since Sb23 can efficiently replace ACE2 from a preformed complex, it has a higher affinity for RBD than ACE2. Biolayer interferometry assay was used to kinetically characterize the interaction of sybodies with RBD and spike (Custodio et al., 2020).
- ApplicationsELISA, Neutralisation/Blocking, Other Application
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDSb23
- Gene ID43740568
- Target nameS
- Target descriptionsurface glycoprotein
- Target synonymsGU280_gp02; spike glycoprotein; surface glycoprotein
- HostRabbit
- IsotypeIgG
- Protein IDP0DTC2
- Protein NameSpike glycoprotein
- Scientific DescriptionThis chimeric rabbit antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.
- ReactivityVirus
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203